Researchers headed by a team at the California Institute of Technology developed an ultrasound-guided 3D printing technique that could make it possible to fabricate medical implants in vivo and ...

High-risk NMIBC is characterised by poor prognosis, with half of patients recurring despite effective treatment with the ...

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing ...

It’s important to note that a myocardial infarction and a stroke, while both serious cardiovascular events, are not the same.

LAS VEGAS -- Event-free survival (EFS) in high-risk non-muscle invasive bladder cancer (NMIBC) improved significantly when ...

Welcome to the Relmada Therapeutics first-quarter 2025 earnings call. (Operator Instructions) As a reminder, this conference is being recorded, and will be available for replay on the location website ...

The FDA issued an RTF for sBLA of nogapendekin alfa plus BCG for BCG-unresponsive NMIBC papillary disease, following prior ...

in non-muscle invasive bladder cancer carcinoma in situ (NMIBC CIS) and updated data on papillary disease without CIS at the American Urological Association Annual Meeting (AUA 2025) in Las Vegas ...

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

The targeted drug release device TAR-200 shows promising response and disease-free survival rates in specific populations of ...

In the darkness of the South Atlantic Ocean, researchers captured for the first time footage of a live colossal squid ( Mesonychoteuthis hamiltoni ). And while the elusive creature is known for its ...